BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38088183)

  • 1. The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.
    Chalif J; Wang H; Spakowicz D; Quick A; Arthur EK; O'Malley D; Chambers LM
    Int J Gynecol Cancer; 2023 Dec; ():. PubMed ID: 38088183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.
    Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C
    Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment.
    Chase D; Goulder A; Zenhausern F; Monk B; Herbst-Kralovetz M
    Gynecol Oncol; 2015 Jul; 138(1):190-200. PubMed ID: 25957158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and gut microbiome interactions in gynecologic cancer.
    AlHilli MM; Bae-Jump V
    Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome and gynaecological cancer development, prevention and therapy.
    Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
    Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbes in gynecologic cancers: Causes or consequences and therapeutic potential.
    Wahid M; Dar SA; Jawed A; Mandal RK; Akhter N; Khan S; Khan F; Jogaiah S; Rai AK; Rattan R
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1179-1189. PubMed ID: 34302959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oncobiome in Gastroenteric and Genitourinary Cancers.
    D'Antonio DL; Marchetti S; Pignatelli P; Piattelli A; Curia MC
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions.
    Borella F; Carosso AR; Cosma S; Preti M; Collemi G; Cassoni P; Bertero L; Benedetto C
    ACS Infect Dis; 2021 May; 7(5):987-1009. PubMed ID: 33848139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harness the functions of gut microbiome in tumorigenesis for cancer treatment.
    Lee MH
    Cancer Commun (Lond); 2021 Oct; 41(10):937-967. PubMed ID: 34355542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.
    Sobstyl M; Brecht P; Sobstyl A; Mertowska P; Grywalska E
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota, an emergent target to shape the efficiency of cancer therapy.
    Kouidhi S; Zidi O; Belkhiria Z; Rais H; Ayadi A; Ben Ayed F; Mosbah A; Cherif A; El Gaaied ABA
    Explor Target Antitumor Ther; 2023; 4(2):240-265. PubMed ID: 37205307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment.
    Zhao X; Liu Z; Chen T
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The female reproductive tract microbiotas, inflammation, and gynecological conditions.
    Gholiof M; Adamson-De Luca E; Wessels JM
    Front Reprod Health; 2022; 4():963752. PubMed ID: 36303679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.
    Jaye K; Li CG; Bhuyan DJ
    Crit Rev Oncol Hematol; 2021 Sep; 165():103429. PubMed ID: 34293459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity.
    Kunika ; Frey N; Rangrez AY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.